Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 3 Insider Initial Statement of Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  10. 8-K Event Other events
  11. 4 Insider Changes in Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Bylaws or fiscal year change
  14. 8-K Event Other events
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Other events
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 21 · 412 filings